Share This Article:

Treatment of Acne Vulgaris with 5-Alpha Avocuta Cream 2% in Comparison with Tretinion Cream 0.025% (Single Blind Comparative Study)

Abstract Full-Text HTML Download Download as PDF (Size:347KB) PP. 179-183
DOI: 10.4236/jcdsa.2012.23034    4,978 Downloads   8,702 Views  

ABSTRACT

Background: Acne vulgaris is a common skin disease. Its pathogenesis is multifactorial, and therapy can now be directed at many of these factors. Among these factors are androgen hormones which play an important role in the pathogenesis of acne. Accordingly,many antiandrogens have been developed to treat acne by systemic and topical ways. Five-Alpha Avocuta 2% cream is a new topical 5-alpha reductase inhibitor extracted from the tropical fruit “avocado”. Objectives: To evaluate the effectiveness and safety of 5-Alpha Avocuta cream and compare it to tretinoin 0.025% cream, in the treatment of acne vulgaris. Patients& Methods: This single blinded comparative study was done in Department of Dermatology– Baghdad Teaching Hospital - from July 2009 through October 2010. All demographic points related to the disease were obtained from each patient to evaluate severity of acne. Sixty-eight patients with acne were divided into two groups and instructed to apply the drugs for three months. Group A uses 5-Alpha avocuta 2% (Teen-derm K) cream and Group B uses tretinoin (Acretin) 0.025% cream. Severe acne was excluded from the study. The clinical improvement was evaluated by counting the number of inflammatory lesions before and after treatment and compare between them by paired t-test. Results: Fifty-eight patients completed the study, their age ranged from 12 - 30 years with a mean of 18.21 ± 4.64 years. In Group A there was a significant reduction of the mean number of papules from 29.7 before treatment to 15.5 after treatment (p < 0.0001), while the mean number of pustules decreased from 4.9 to 0.6 (p = 0.019). In Group B the mean number of papules was reduced from 28.5 to 14.9 (p < 0.0001), while the mean number of pustules dropped from 5.3 before treatment to 0.7 after treatment (p = 0.009). The mean difference of papules after 14 weeks in Group A was 15.55 ± 6.95 while in Group B, the mean difference was 14.86 ± 6.99. This result was statistically not significant (p = 0.708, t-test). The difference in the mean percentage of reduction of inflammatory lesions at week 14 between the two groups was not statistically significant (P-value = 0.999).The side effect was negligible in Group A and not required stopping the drug while in Group B treatment stopped in 2 patients. Conclusions: Five Alpha avocuta was an effective mode of therapy in treatment of acne vulgaris, and it was comparable to tretinoin, with little side effects.

Cite this paper

K. Sharquie, H. Al-Hamamy, A. Noaimi and A. Tahir, "Treatment of Acne Vulgaris with 5-Alpha Avocuta Cream 2% in Comparison with Tretinion Cream 0.025% (Single Blind Comparative Study)," Journal of Cosmetics, Dermatological Sciences and Applications, Vol. 2 No. 3, 2012, pp. 179-183. doi: 10.4236/jcdsa.2012.23034.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] W. D. James, T. G. Berger and D. M. Eleston, “Andrews’ Disease of the Skin: Clinical Dermatology,” 9th Edition, Saunders Elsevier, Philadelphia, 2006, pp. 284-306.
[2] J. Tan, “Hormonal Treatment of Acne: Review of Current Best Evidence,” Journal of Cutaneous Medicine and Surgery, Vol. 8, No. 4, 2004, pp. 11-15. doi:10.1007/s10227-004-0754-8
[3] W. J. Cunliff and N. B. Simpson, “Disorders of Sebaceous Glands,” In: A. Rook and D. S. Wilkinson, Eds., Ebling FJE Text Book of Dermatology, 6th Edition Blackwell Scientific Publication, Hoboken, 1998, pp. 1927-1984.
[4] N. Piccardi, A. Piccirilli, J. C. Choulot, B. Chadoutaud and P. Msika, “Pharmacological and Clinical Activities of Alpha Avocuta: Application for the Management of Androgenic Disorders,” 34th Annual European Society for Dermatological Research (ESDR) Meeting, Vienna, 9-11 September 2004.
[5] P. H. Thomas, S. Bhambri, J. Q. Del Rosso and A. Bhambri, “Clinical Dermatology, Etiology and Pathogenesis of Acne,” 5th Edition, Elsevier, Amsterdam, 2010.
[6] M. Stucker, U. Memmel, M. Hoffmann, J. Hartung and P. Altmeyer, “Vitamin B12 Cream Containing Avocado Oil in the Therapy of Plaque Psoriasis,” Dermatology, Vol. 203, No. 2, 2001, pp. 141-147. doi:10.1159/000051729
[7] S. Bredif, C. Baudouin, E. Et Loir and P. Msika, “Anti-Itching Properties of Patented Avocado Peptides,” 68th Annual Meeting of the American Academy of Dermatology, Miami, 5-9 March 2010, p. 1601.
[8] G. Rosenblat, S. Meretski, J. M. Segal, A. Schroeder, A. Zanin-Zhorov, G. A. Lion and M. Hochberg, “Polyhydroxylated Fatty Alcohols Derived from Avocado Suppress Inflammatory Response and Provide Non-Sunscreen Protection against UV-Induced Damage in Skin Cells,” Archives of Dermatological Research, Vol. 303, No. 4, 2011, pp. 239-246.
[9] N. Piccardi, N. Broutin, S. Garnier, J. Legrand, J. Choulot, B. Chadoutaud and P. Msika, “Avocado Sugars Are Effective Inducer of Cutaneous Defensive Functions,” Journal of the American Academy of Dermatology, Vol. 56, No. 2, 2007, p. 84.
[10] A. Shalita, J. S. Weiss, D. K. Chalker, C. N. Ellis, A. Greenspan, H. I. Katz, I. Kantor, L. E. Millikan, T. Swinehart, L. Swinyer, J. C. Whitmore, M. Baker and J. Czemielewski, “A Comparison of the Efficacy and Safety of Adapalene Gel 0.1% and Tretinoin Gel 0.025% in the Treatment of Acne Vulgaris: A Multicenter Trial,” American Academy of Dermatology, Vol. 34, No. 3, 1996, p. 48.
[11] B. Burke, E. A. Eady and W. J. Cunliffe, “Benzoyl Peroxide versus Topical Erythromycin in the Treatment of Acne Vulgaris,” British Journal of Dermatology, Vol. 108, No. 2, 1983, pp. 199-204. doi:10.1111/j.1365-2133.1983.tb00063.x
[12] A. K. Zubaidy, N. A. Matloob and F. H. Al-Jawad, “Comparative Study of Topical Finasteride as a New Therapy of Acne Vulgaris,” The New Iraqi Journal of Medicine, Vol. 3, 2004, pp. 117-124.

  
comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.